Hologic (HOLX) Tops Q1 EPS by 69c, Revenues Beat; Offers 2Q EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Hologic Announces Financial Results for First Quarter of Fiscal 2021
January 27, 2021 4:01 PM ESTRevenue of $1.61 Billion Increases 89.3%, 86.5% in Constant Currency
Organic Revenue Increases 107.0%, 104.0% in Constant Currency
Company Posts GAAP Diluted EPS of $2.50, Non-GAAP Diluted EPS of $2.86
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal first quarter ended December 26, 2020.
Hologic had a strong start to fiscal 2021 across all our businesses and major geographies, said Steve MacMillan, the Companys Chairman, President and Chief Executive Officer. Our Diagnostics division continued to deliver incredible performance by making a massive impact against... More
